Results 271 to 280 of about 339,433 (382)
Proceedings of the International creatine conference 2025 - Munich, Germany. [PDF]
Bonilla DA, Stout JR, Kreider RB.
europepmc +1 more source
FORMATION OF CREATINE IN VITRO FROM METHYL PHOSPHATE AND GUANIDOACETIC ACID
Francis Binkley, Jean Watson
openalex +1 more source
Schematic diagram of the single and dual RPA‐CRISPR/Cas12a/13a diagnostic assays for the detection of Pantoea stewartii subsp. stewartii and Maize dwarf mosaic virus. The validated assays provide a useful and sensitive molecular tool for detecting two quarantine pathogens of maize within a minimal resource framework suitable for fast‐tracking the ...
Qian Tian +6 more
wiley +1 more source
Evaluation of SLC6A8 species conservation and the effect of pathogenic variants on creatine transport. [PDF]
Diep T, Lipshutz GS.
europepmc +1 more source
Abstract Infantile‐onset Pompe disease (IOPD) is a rare, deadly, quickly‐progressing degenerative disease. Even with life‐sustaining treatment (e.g., alglucosidase alfa [ALGLU]), many patients experience continued motor impairment. The Mini‐COMET trial evaluated avalglucosidase alfa (AVAL) versus ALGLU on motor and other outcomes in IOPD.
Fatiha Rachedi +6 more
wiley +1 more source
Resistance of mature and elderly bodybuilders to anaerobic energy supply load. [PDF]
Chernozub A +8 more
europepmc +1 more source
Approach to asymptomatic creatine kinase elevation
S. Moghadam-Kia, C. Oddis, R. Aggarwal
semanticscholar +1 more source
Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B Patients
ABSTRACT Pegbing (peginterferon alpha‐2b) is a polyethylene glycol‐modified interferon α‐2b injection that has demonstrated favorable efficacy and safety profiles in the treatment of chronic hepatitis B (CHB). This study aimed to develop a population pharmacokinetic (PopPK) model of Pegbing in both healthy subjects and CHB patients and to investigate ...
Weizhe Jian +11 more
wiley +1 more source

